Chemclin Diagnostics Co., Ltd. (SHA:688468)
6.16
-0.01 (-0.16%)
Aug 4, 2026, 3:00 PM CST
Chemclin Diagnostics Revenue
Chemclin Diagnostics had revenue of 73.35M CNY in the quarter ending March 31, 2026, a decrease of -9.78%. This brings the company's revenue in the last twelve months to 324.73M, down -20.06% year-over-year. In the year 2025, Chemclin Diagnostics had annual revenue of 332.68M, down -23.75%.
Revenue (ttm)
324.73M
Revenue Growth
-20.06%
P/S Ratio
7.49
Revenue / Employee
559.87K
Employees
580
Market Cap
2.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 332.68M | -103.61M | -23.75% |
| Dec 31, 2024 | 436.29M | -9.05M | -2.03% |
| Dec 31, 2023 | 445.34M | -19.93M | -4.28% |
| Dec 31, 2022 | 465.27M | -5.50M | -1.17% |
| Dec 31, 2021 | 470.77M | 52.57M | 12.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.85B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Amoy Diagnostics | 1.19B |
| Thalys Medical Technology Group | 971.32M |
| Berry Genomics Co.,Ltd | 922.27M |
| SMO ClinPlus CO.,LTD. | 860.07M |